Executives/Ipsen CEO
David Loew, CEO of Ipsen

Who is the CEO of Ipsen in 2026?

David Loew is the Chief Executive Officer of Ipsen. David has held the CEO seat since July 2020, and was previously Executive Vice President Vaccines at Sanofi.

Updated September 24, 2026
Time in seat
6 years
CEO since July 2020
Career span
33 years
First recorded role December 1992
Education
INSEAD
Certification for Board Directors in Corporate Governance
Summary
  • Before Ipsen, David Loew was Executive Vice President Vaccines at Sanofi from June 2016 to July 2020.
  • David Loew sits on the boards of EFPIA - European Federation of Pharmaceutical Industries and Associations and PhRMA.
  • David Loew sat on the board of Gavi, the Vaccine Alliance from June 2016 to December 2017.

Current company

Ipsen

Ipsen is a French biopharmaceutical company.

activities of head officesHeadquartered in ParisFounded 1929

Source: Wikipedia

Career and education

David Loew has been CEO of Ipsen since July 2020. Before Ipsen, David was Executive Vice President Vaccines at Sanofi from June 2016 until July 2020.

Career

  1. Ipsen2020 to present
    • Chief Executive Officer
  2. EFPIA - European Federation of Pharmaceutical Industries and Associations2020 to present
    • Board MemberJuly 2020 to present
    • June 2023 to June 2025
  3. PhRMA2020 to present
    • Board member
  4. Sanofi2013 to 2020
    • Executive Vice President VaccinesJune 2016 to July 2020
    • COO, Head global commercial operations vaccinesJanuary 2016 to May 2016
    • SVP Region Europe Pharma, OTC, GxJuly 2013 to December 2015
  5. Gavi, the Vaccine Alliance2016 to 2017
    • Board Member
  6. Roche1992 to 2013
    • Head Region Eastern Europe, Middle East and Africa (EEMEA)March 2013 to June 2013
    • Chief Marketing Officer and Head Global Product StrategyJanuary 2010 to February 2013
    • General Manager PharmaJuly 2007 to November 2009
    • Therapeutic area head oncology, ad interimJanuary 2007 to June 2007
    • Life Cycle Leader MabThera (rituximab)January 2006 to December 2006
    • Life Cycle Leader Xeloda (capecitabine)November 2001 to December 2005
    • Business Unit HeadFebruary 1999 to October 2001
    • Marketing Manager Transplantation and DialysisMay 1995 to January 1999
    • Management Development ProgramSeptember 1993 to April 1995
    • Sales RepresentativeDecember 1992 to August 1993
  7. Roche Headquarters1993 to 2005
    • Life Cycle Leader Xeloda (capecitabine)November 2001 to December 2005
    • Management Development ProgramSeptember 1993 to April 1995
  8. Roche México1999 to 2001
    • Business Unit Head
  9. Roche France1995 to 1999
    • Marketing Manager Transplantation and Dialysis
  10. Roche Austria1992 to 1993
    • Sales Representative

Sources: LinkedIn profile

Education

INSEAD, Certification for Board Directors in Corporate GovernanceUniversity St.Gallen, Master of Business Administration (M.B.A.), Finance and controllingSource

Decision makers by function

300+ decision makers at Ipsen in Unify, vice president level and above. Choose a function to see who leads it.

Decision maker preview

Top decision makers at Ipsen

Vice president level and above, most senior first
Bertrand LavironSVP Supply Chain · FRA@ipsen.com
Lisa MarsdenSenior Vice President, Global Market Access & Pricing · GBR@ipsen.com
Jennifer GlennonSenior Vice President, Global Portfolio Operations · USA@ipsen.com
Michael SilberbergSVP, Head of Global Medical Affairs, Aesthetics · GBR@ipsen.com
See every decision maker at Ipsen

Unlock every decision maker at Ipsen

Get verified profiles, contact data, and live buying signals in Unify.

Leadership team at Ipsen

David Loew leads a leadership team of 12 published executives.

Most senior 5 of 12

NameTitleIn seat since
David LoewChief Executive OfficerJuly 2020
Aymeric Le ChatelierExecutive Vice President, Chief Financial OfficerNot stated
Caroline SitbonExecutive Vice President, General CounselNot stated
Philippe Lopes-FernandesExecutive Vice President, Chief Business OfficerNot stated
Sandra SilvestriExecutive Vice President, Chief Medical OfficerNot stated

Sources: Ipsen Executive Leadership Team page

Frequently asked questions

Who is the CEO of Ipsen?

David Loew is the Chief Executive Officer of Ipsen. David has held the CEO seat since July 2020, and was previously Executive Vice President Vaccines at Sanofi.

When did David Loew become CEO of Ipsen?

David Loew has been CEO of Ipsen since July 2020, according to LinkedIn profile.

What did David Loew do before Ipsen?

David Loew was Executive Vice President Vaccines at Sanofi from June 2016 until July 2020, according to LinkedIn profile.

How long has David Loew been CEO of Ipsen?

David Loew has been CEO of Ipsen for 6 years, since July 2020.

Who else leads Ipsen?

Aymeric Le Chatelier (Executive Vice President, Chief Financial Officer), Caroline Sitbon (Executive Vice President, General Counsel), Philippe Lopes-Fernandes (Executive Vice President, Chief Business Officer), Sandra Silvestri (Executive Vice President, Chief Medical Officer), and 7 more. Source: Ipsen Executive Leadership Team page.

Reach Ipsen's decision makers

300+ leaders at vice president level and above, with verified work emails and phone numbers in Unify.

Methodology

The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.

Identity confirmed against Wikipedia, Ipsen. Last verified: September 24, 2026.